Liver Diseases
Interferon-stimulated gene 15 in hepatitis B-related liver diseases
... Statistical analyses were performed using R version 3.1.2 (http://www.r-project.org) and GraphPad Prism 6 (http://www.graphpad.com) . Hardy-Weinberg equilibrium deviations were calculated according to the Guo & ...
11
Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases
... Liver diseases represent a major health problem with significant morbidity and ...severe liver failure [35]. Since the liver plays a vital and complex role in various metabolic and synthetic ...
7
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
... cholestatic diseases are purely intrahepatic, whereas sclerosing cholangitis may affect small and large intrahe- patic and/or extrahepatic bile ...cholestatic liver diseases including certain rare ...
31
Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
... of diseases, including liver disease and inflammatory bowel ...including liver diseases (more than 40 trials) and inflammatory bowel diseases (more than 20 ...in liver disease ...
15
Autoimmune Liver Diseases in Native Black Africans: Extremely Rare or Inadequately Investigated Diseases?
... Autoimmune liver diseases (AILDs) are rare diseases globally with a reported prevalence of less than 50 per 100,000 people ...related diseases, has emerged recently [3,4]. Though the ...
14
The economic cost and health burden of liver diseases in Australia. The Gastroenterological Society of Australia/Australian Liver Association
... of liver disease in Australia: first, a GESA-led education program to increase awareness of chronic liver diseases through collaboration with Medicare Locals and GESA/ALA; and second, a nurse-led ...
90
Drug-Induced Liver Diseases in Children and Adolescents
... Drug-induced liver disorders (DILD) are the diverse group of clinicomorphological types of liver injury caused by drug ...concomitant diseases (obesity\poor nutritive status, diabetes mellitus), ...
8
Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases
... the liver after transplant- ation; 4) determining the number of cells required for various diseases; and 5) identifying the possible risks of LHMSC ...
8
Nanocarrier-mediated antioxidant delivery for liver diseases
... nanocarrier-mediated liver diseases has grown rapidly in recent years and has shown great application prospects [122, ...Taking liver cancer as an example, tumor cells are significantly different ...
19
Emerging roles of SIRT1 in fatty liver diseases
... fatty liver diseases treatment and have been advanced to phase IV clinical trials for metabolic diseases, there are still some unsolvable limitations for them as clinical drugs, including ...
16
Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER
... rare liver condition currently benefit from effect- ive or curative therapies, and many do not have a defin- ite ...Rare Liver Diseases which helps to inform the wider sci- entific community about ...
8
A REVIEW OF SIDDHA TRADITIONAL SYSTEM PRODUCTS AND THEIR INGREDIENTS IN LIVER DISEASES
... It is observed that some of the formulations are broad-based being used in variety of liver disorders whereas others are specific to a liver disease. The ingredients are also for general or specific use in ...
20
Neuroinflammation and neurological alterations in chronic liver diseases
... than two million people suffer from MHE in USA, in the European Union and even more in the rest of the world. Minimal hepatic encephalopathy has important consequences on daily life of patients with chronic liver ...
7
Cell-based therapies of liver diseases: age-related challenges
... of liver diseases with an emphasis on cell donor’s and patient’s ...of liver disease treatment in people of different ages and vigorous research and technological innovations in this area are in ...
16
Biological Significance of Local TGF-β Activation in Liver Diseases
... Based on the TGF-β signaling pathway, four major strategies allowing the modulation of TGF-β availability have emerged. The first strategy is to block the production of TGF- β using anti-sense oligonucleotide mRNA; a ...
11
Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
... of liver diseases, the increasing num- ber of patients with HCC and the high benefit in sur- vival by liver transplantation to patients with ...for liver transplantation for HCC have ...for ...
5
Classification for Liver Diseases Based on Ultrasound Image Texture Features
... Liver diseases are ones of the most life-threatening causes ...of liver diseases, liver cancer and liver abscess, which have the high mortality rate, are the most dangerous ...of ...
37
DIFFERENT MODELS OF HEPATOTOXICITY AND RELATED LIVER DISEASES: A REVIEW
... persistent parenchymal focal hepatocyte necrosis (apoptosis) with mononuclear sinusoidal infiltrates. This is now referred to as 'chronic hepatitis without piecemeal necrosis (or interface hepatitis). These terms have ...
10
Signal Transducer and Activator of Transcription 4 in Liver Diseases
... the liver of several mouse models of liver injury, as well as the human liver of chronic liver ...drug-induced liver injury (DILI), primary biliary cirrhosis (PBC), HCV-associated ...
8
Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases
... of liver inflammation and fibrosis, and the possible use of MSCs in the therapy of immune-mediated liver ...of liver infiltrated inflammatory cells and compare effects of engrafted MSCs versus ...
9